Recurrent Erysipelas: 47 CasesLeclerc S.a, b · Teixeira A.a · Mahé E.b · Descamps V.b · Crickx B.b · Chosidow O.a
aDepartment of Internal Medicine, Hôpital de la Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie-Paris 6, bDepartment of Dermatology, Hôpital Bichat-Claude-Bernard, Université Paris VII, Paris, France
Background:Recurrence is a common complication of erysipelas (cellulitis). Objectives:Todescribe the characteristics of patients with recurrent erysipelas and thereby, identify potential risk factors and evaluate prophylaxis efficacy. Methods:Data were retrospectively recorded from the files of 47 patients admitted to hospital between 1995 and 2003 for erysipelas recurrence. Studied variables included: general condition, regional and local factors, e.g. broken cutaneous barrier. Patient characteristics were used to construct tree-based models according to the classification and regression tree methodology. Results: Our patients suffered a mean of 4.1 recurrences. Cutaneous barrier disruption was observed in 81%, mainly intertrigo (60%). Antibiotic prophylaxis was taken by 68% of the patients for 30.6 months. After 1 and 2 years, 84 and 72% of the patients, respectively, were recurrence-free. Conclusion: Our results showed that erysipelas recurrence has the same risk factors as single episodes and underlines the potential benefit of oral or parenteral antibiotic prophylaxis to prevent recurrences.
© 2007 S. Karger AG, Basel
Department of Dermatology and Allergology, Hôpital Tenon
4 rue de la Chine, FR–75020 Paris (France)
Tel. +33 1 56 01 76 72, Fax +33 1 56 01 64 58
Presented in part at the ‘Journées Dermatologiques de Paris’, 12 December 2003.
Received: June 9, 2006
Accepted: July 28, 2006
Number of Print Pages : 6
Number of Figures : 3, Number of Tables : 2, Number of References : 25
Vol. 214, No. 1, Year 2007 (Cover Date: December 2006)
Journal Editor: Saurat, J.-H. (Geneva)
ISSN: 1018–8665 (print), 1421–9832 (Online)
For additional information: http://www.karger.com/DRM